The global neurosurgical ablation market was valued at USD 514.6 million in 2019. Rising burden of cancer worldwide and rising healthcare expenditures has sparked a surge in demand for neurosurgical ablation devices. The technological advancements in ablation instruments, and increasing demand for minimally invasive surgeries worldwide are certain factors that are propelling the growth of the global neurosurgical ablation market.
Neurosurgery is the medical specialty dealing with the diagnosis and treatment of patients with injuries to, or disease/disorders of the brain, spinal cord, spinal column, and peripheral nerves within all parts of the body. The neurosurgical care specialty involves both adult and paediatric patients. A neurological surgeon may provide surgical and/or non-surgical treatment depending on the nature of the injury or illness. Cancer is a social burden in all the world's major nations. According to the American Cancer Society 2020, in US there were an estimated 23,820 new cases of malignant brain tumors were diagnosed in 2020. Globally, nearly one in every six deaths is due to cancer. Low and middle-income nations account for about 70% of all cancer deaths. This is largely due to inadequate healthcare in certain nations or a lack of adequate care for the disease. This is anticipated to boost the demand for neurosurgical ablation devices during the forecast period.
The market growth is primarily driven by the growing acceptance of minimally invasive neurosurgeries. Patients favour minimally invasive surgery as the recovery time is short, and surgeons use a range of techniques during surgery to minimize body tissue damage. This procedure minimizes the risk of operation and, as opposed to conventional operation technique, this technique requires smaller incisions and fewer instruments. This technique minimizes incisions as well as helps surgeons to cover scars cosmetically. Minimally invasive treatments are also used in applications such as brain cancers and benign brain tumors. Patients recover quicker because of less invasive surgeries, and surgeons have more time to devote it to other surgeries. Thus, surgeons advocate minimally invasive surgeries to patients when conducting neurosurgeries because of their benefits compared to the conventional mode of care, which is leading to an increased demand for neurosurgical ablation devices.
The global neurosurgical ablation market is categorized based on product type, end-users and region. On the basis of product type, the accessories segment held the largest share of the global neurosurgical ablation market in 2020 owing to its wide application in neurosurgeries. Geographically, North America dominated the global neurosurgical ablation market in 2020, however, Asia Pacific is expected to be the fastest growing region by 2028.
Key players operating in the global neurosurgical ablation market include Medtronic plc, INSIGHTEC Ltd., Monteris Medical, Inc., MRI Interventions, Inc., Boston Scientific Corporation, and Angio Dynamics Inc. among others.
Key Segments of the Global Neurosurgical Ablation Market
Product Type Overview, 2019-2028 (USD Million)
- MRI Guided RF Ablation Systems
- MRI Guided Focused Ultrasound Systems
- MRI Guided Laser Ablation Systems
End-Users Overview, 2019-2028 (USD Million)
- Ambulatory Surgical Centers
Regional Overview, 2019-2028 (USD Million)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
Reasons for the study
- Increasing prevalence of brain tumors and other nervous system associated disorders
- Rising adoption of less invasive neurosurgeries around the world
- Rising awareness of early brain disorder diagnosis and treatment through government campaigns
What does the report include?
- The study on the global neurosurgical ablation market includes qualitative insights such as drivers, restraints, challenges and opportunities
- Additionally, the market has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of product type and end-users. Moreover, the study on neurosurgical ablation market provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players operating in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global neurosurgical ablation market is suitable for all the players across the value chain including raw medical material suppliers, hospitals, long-term care facilities, neurosurgeons clinics, ambulatory surgical centers, medical device manufacturers, healthcare organizations, distributors, suppliers and wound type geeks
- Venture capitalists and investors looking for more information on the future outlook of the global neurosurgical ablation market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global neurosurgical ablation market
The need for neurosurgical ablation has significantly increased owing to the increasing number of patients suffering from cancer. According to the World Cancer Research Fund International data report 2018, around 296,851 new cases of brain and central nervous system cancer were diagnosed globally in 2018. The world's high prevalence of cancer puts a high economic burden on countries. The need for improved diagnosis and treatment for cancer has also increased. Government organizations such as the World Health Organization, National Cancer Institute, Cancer Research United Kingdom, etc. are actively making efforts to minimize the incidence of cancer and build more awareness of the disease's prevention and cure. These conditions have contributed to a rise in concern in most patients and which resulted in flourish in the demand for neurosurgical ablation worldwide.
Several campaigns are being pursued to spread awareness related to early brain disease diagnosis and treatment by various governments and private organisations. For example, the month of May is being considered as “Brain Tumor Awareness Month”. The "It's Your Fight, It's Our Fight" initiative by the National Brain Tumor Society seeks to educate and engage individuals through events that can contribute to increased awareness and cure of brain tumours. Similarly, the Brain Tumor Charity sponsored HeadSmart national awareness initiative aims to reduce brain tumours in childhood and cancer diagnosis periods to 4 weeks or less. This increasing understanding of treatment and diagnosis among people is likely to fuel the growth of this market.
In addition, an increasing number of cases of neurological disorders, including brain tumours, have driven the launch of technologically advanced products on the market in developed and developing countries. For example, for the treatment of essential tremor and tremor dominant PD, Insightec's MR-guided oriented ultrasound (MRgFUS) is used. This procedure is incision-free and produces ultrasound beams, thereby heating the brain and removing targeted tissue. Therefore, industry players are making relentless efforts for introducing technologically advanced products.
The global neurosurgical ablation market has been segmented based on product type, end-users and region. Based on product type, the neurosurgical ablation market is segmented into MRI-guided RF ablation systems, MRI-guided laser ablation systems, MRI-guided focused ultrasound systems, and accessories wherein the accessories segment dominated the market. Accessories have wide application in neurosurgeries. For performing surgeries, there are various accessories used, such as curettes used for delicate and precise neurosurgeries, rongeurs used in neurosurgery to open a window in the skull bone, and dissectors that enable a minimally invasive discectomy to be performed by neurosurgeons. These accessories are designed to aid in the diagnosis and reconstruction of the central nervous system by neurosurgeons. Since neurosurgeons regularly operate on the human body's most fragile nervous system, they need some accessories that can assist in their surgical care. Thus, benefits offered by the accessories segment are expected to fuel the segment growth.
On the basis of end-users, the neurosurgical ablation market is segmented into hospitals, clinics, and ambulatory surgical centers. The hospital segment dominated the market as hospitals consist of an autonomous neurosurgery department that comprises an experienced team of senior consultants and are assisted by a qualified support team that helps them function effectively. Hence, hospital segment is the dominating end-user for neurosurgical ablation devices.
The global neurosurgical ablation market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global neurosurgical ablation market in 2020, however Asia Pacific is expected to grow at a highest pace through 2028.
North America, especially the U.S. dominates the global neurosurgical ablation market. This is due to the existence of well-established healthcare facilities in the area, growing prevalence of brain cancers as well as malignant tumours in the brain, and the availability of highly qualified neurosurgeons. Furthermore, the involvement of major players such as Medtronic, Boston Scientific Corporation and Insightec Ltd. contributes to the growth of the region's market. The market is thus mainly guided by a growing number of minimally invasive neurosurgical procedures as well the availability of technologically advanced products.
Asia Pacific is expected to be the fastest growing regional market for neurosurgical ablation owing to factors such as the existence of a large patient base, growing medical tourism, rising healthcare spending by the government, and acceptance of minimally invasive surgeries. In addition, countries in this area are expanding their intensive care facilities in hospitals and other outpatient neurosurgery facilities, as a significant number of people are suffering from brain cancer, Alzheimer's disease, and many other disorders of the nervous system. Thus, Asia Pacific is expected to be the fastest growing regional market for neurosurgical ablation devices during the forecast period.